Rosiglitazone improves β-cell function as measured by proinsulin/insulin ratio in patients with type 2 diabetes

被引：0
|
作者：
Porter, LE
Freed, MI
Jones, NP
Biswas, N
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
495
引用
收藏
页码：A122 / +
页数：2
相关论文
共 50 条
  • [1] Rosiglitazone reduces proinsulin/insulin ratio and improves β-cell function in type 2 diabetes
    Porter, LE
    Freed, MI
    Jones, NP
    Biswas, N
    [J]. DIABETOLOGIA, 2000, 43 : A192 - A192
  • [2] Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes
    Smith, SA
    Porter, LE
    Biswas, N
    Freed, MI
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12): : 6048 - 6053
  • [3] Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Papafaklis, Michail I.
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 195 - 201
  • [4] Rosiglitazone decreases insulin resistance and improves beta-cell function in patients with type 2 diabetes.
    Matthews, DR
    Bakst, A
    Weston, WM
    Hemyari, P
    [J]. DIABETOLOGIA, 1999, 42 : A228 - A228
  • [5] The insulin sensitizer rosiglitazone improves endothelial function in insulin-dependent patients with type 2 diabetes
    Naka, K.
    Papathanassiou, K.
    Kazakos, N.
    Bechlioulis, A.
    Pappas, K.
    Liveris, K.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 466 - 466
  • [6] P.050 The Insulin Sensitizer Rosiglitazone Improves Endothelial Function in Patients with Type 2 Diabetes on Insulin
    K. Papathanassiou
    K. K. Naka
    N. Kazakos
    K. Pappas
    K. Liveris
    D. Makriyiannis
    A. Tsatsoulis
    L. K. Michalis
    [J]. Artery Research, 2006, 1 (Suppl 1) : S39 - S39
  • [7] Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women
    Pradhan, AD
    Manson, JE
    Meigs, JB
    Rifai, N
    Buring, JE
    Liu, SM
    Ridker, PM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 114 (06): : 438 - 444
  • [8] Effects of the addition of pioglitazone on insulin resistance, beta cell function and proinsulin/insulin ratio in patients with type 2 diabetes inadequately controlled on metformin and a sulphonylurea
    Halimi, S.
    Charpentier, G.
    [J]. DIABETOLOGIA, 2006, 49 : 491 - 492
  • [9] Rosiglitazone might improve β-cell function in patients with type 2 diabetes
    不详
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (6): : 442 - 442
  • [10] Rosiglitazone improves postprandial glycaemia and markers of endothelial function in patients with Type 2 diabetes
    Agrawal, A
    Chen, H
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    [J]. DIABETOLOGIA, 2002, 45 : A251 - A251
12345